ADDENDUM - SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE IN LUNG CANCER

NIH GUIDE, Volume 24, Number 12, March 31, 1995



RFA:  CA-95-008



P.T. 34



Keywords:

  Cancer/Carcinogenesis 

  Pulmonary Diseases 

  Etiology 

  Diagnosis, Medical 

  Disease Prevention+ 

  Treatment, Medical+ 



National Cancer Institute



Application Receipt Date:  June 23, 1995



The National Cancer Institute (NCI) announces the following

modification to RFA CA-95-008, which was published in the NIH Guide,

Vol. 24, No. 5, February 10, 1995.



Under ELIGIBILITY REQUIREMENTS, an alternative to a minimum of three

independent investigators who are successful in obtaining

peer-reviewed research support directly related to lung cancer, is a

minimum of three independent investigators, each having published

articles in peer-reviewed research journals, that significantly

address lung cancer and who as a group represent experience in both

laboratory and clinical research.



INQUIRIES



Andrew Chiarodo, Ph.D.

Division of Cancer Biology, Diagnosis, and Centers

National Cancer Institute

6130 Executive Boulevard, Suite 512

Bethesda, MD  20852

Telephone:  (301) 496-8528

FAX:  (301)402-0181

Email:  chiarodoa@dcbdcep.nci.nih.gov



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.